Ritonavir Completed Phase 4 Trials for Human Immunodeficiency Virus (HIV)

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT01615601An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients
NCT01541085An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
NCT01232127Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection